In Association With Abacus Medicine Pharma Services
Future Pharma Services
Covid-19, clinical trials, and the new normal: data shows decentralisation is here to stay
Many new approaches to clinical research were pressed forward during the Covid-19 pandemic, most notably the move towards decentralisation. As we finally enter the ‘new normal’, Pharmaceutical Technology explores what looks like a short-term fix and what’s here to stay.
Abacus Medicine Pharma Services managing director Simon Estcourt on company rebrand
The importance of reference products in biosimilar trials, and how to source them
Are clinical trials headed towards decentralisation?
Solving clinical trial delays: Three things to do now
The future of clinical trials in a post-Covid world
